Effects of parathyroidectomy on plasma PTH fragments and heart rate variability in stage 5 chronic kidney disease patients

References

• Tonelli M, Karumanchi SA, Thadhani R. Epidemiology and mechanisms of uremia-related cardiovascular disease. Circulation. 2016;133(5):518–536.
   PubMed Web of Science ®Google Scholar
• Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2019 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2019; 73:A7–A8.
   PubMed Web of Science ®Google Scholar
• Yang B, Lu C, Wu Q, et al. Parathyroid hormone, cardiovascular and all-cause mortality: a meta-analysis. Clin Chim Acta. 2016;455:154–160.
   PubMed Web of Science ®Google Scholar
• Bellorin-Font E, Vasquez-Rios G, Martin KJ. Controversies in the management of secondary hyperparathyroidism in chronic kidney disease. Curr Osteoporos Rep. 2019;17(5):333–342.
   PubMed Web of Science ®Google Scholar
• Seiler-Mussler S, Limbach AS, Emrich IE, et al. Association of nonoxidized parathyroid hormone with cardiovascular and kidney disease outcomes in chronic kidney disease. Clin J Am Soc Nephrol. 2018;13(4):569–576.
   PubMed Web of Science ®Google Scholar
• Komaba H, Taniguchi M, Wada A, et al. Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int. 2015;88(2):350–359.
   PubMed Web of Science ®Google Scholar
• Clyne N, Hellberg M, Kouidi E, et al. Relationship between declining glomerular filtration rate and measures of cardiac and vascular autonomic neuropathy. Nephrology. 2016;21(12):1047–1055.
   PubMed Web of Science ®Google Scholar
• Rantanen JM, Schmidt EB, Riahi S, et al. Marine n-3 PUFA, heart rate variability and ventricular arrhythmias in patients on chronic dialysis: a cross-sectional study. Br J Nutr. 2018;120(3):317–325.
   PubMed Web of Science ®Google Scholar
• Wang Q, Cui Y, Yogendranath P, et al. Blood pressure and heart rate variability are linked with hyperphosphatemia in chronic kidney disease patients. Chronobiol Int. 2018;35(10):1329–1334.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wu H, Zhang X, et al. Sleep heart rate variability assists the automatic prediction of long-term cardiovascular outcomes. Sleep Med. 2020;67:217–224.
   PubMed Web of Science ®Google Scholar
• Zhang LN, Yang G, Cheng C, et al. Plasma FGF23 levels and heart rate variability in patients with stage 5 CKD. Osteoporos Int. 2015;26(1):395–405.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Shen Z, Zhang J, et al. Parathyroidectomy increases heart rate variability and leptin levels in patients with stage 5 chronic kidney disease. Am J Nephrol. 2016;44(3):245–254.
   PubMed Web of Science ®Google Scholar
• Huimin C, Ying C, Changying X, et al. Effects of parathyroidectomy on plasma iPTH and (1-84) PTH levels in patients with stage 5 chronic kidney disease. Horm Metab Res. 2018;50(10):761–767.
   PubMed Web of Science ®Google Scholar
• Kritmetapak K, Pongchaiyakul C. Parathyroid hormone measurement in chronic kidney disease: from basics to clinical implications. Int J Nephrol. 2019;2019:5496710.
   PubMed Web of Science ®Google Scholar
• Gruson D, Lepoutre T, Ahn SA, et al. Comparison between intact and bioactive parathyroid hormone assays in patients with severe heart failure. Clin Biochem. 2013;46(4-5):391–394.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yu X, Sun B, et al. Parathyroidectomy and heart rate variability in patients with stage 5 CKD. Clin J Am Soc Nephrol. 2013;8(8):1378–1387.
   PubMed Web of Science ®Google Scholar
• Ketteler M, Block GA, Evenepoel P, et al. Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: synopsis of the kidney disease: improving global outcomes 2017 clinical practice guideline update. Ann Intern Med. 2018;168(6):422–430.
   PubMed Web of Science ®Google Scholar
• Zhang L, Xing C, Shen C, et al. Diagnostic accuracy study of intraoperative and perioperative serum intact PTH level for successful parathyroidectomy in 501. Sci Rep. 2016;6(1):26841.
   PubMed Web of Science ®Google Scholar
• Chen H, Han X, Cui Y, et al. Parathyroid hormone fragments: new targets for the diagnosis and treatment of chronic kidney disease-mineral and bone disorder. Biomed Res Int. 2018;2018:9619253.
   PubMed Web of Science ®Google Scholar
• Waziri B, Duarte R, Naicker S. Chronic kidney disease-mineral and bone disorder (CKD-MBD): current perspectives. Int J Nephrol Renovasc Dis. 2019;12:263–276.
   PubMed Web of Science ®Google Scholar
• Tabibzadeh N, Karaboyas A, Robinson BM, et al. The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation. Nephrol Dial Transplant. 2021;36(1):160–169.
   PubMed Web of Science ®Google Scholar
• Lee M, Partridge NC. Parathyroid hormone signaling in bone and kidney. Curr Opin Nephrol Hypertens. 2009;18:298–302.
   PubMed Web of Science ®Google Scholar
• Thomas SS, Mitch WE. Parathyroid hormone stimulates adipose tissue browning: a pathway to muscle wasting. Curr Opin Clin Nutr Metab Care. 2017;20:153–157.
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Lorenzo V. Parathyroid hormone, a uremic toxin. Semin Dial. 2009;22:363–368.
   PubMed Web of Science ®Google Scholar
• Brossard JH, Lepage R, Cardinal H, et al. Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays. Clin Chem. 2000;46(5):697–703.
   PubMed Web of Science ®Google Scholar
• Inaba M, Okuno S, Imanishi Y, et al. Increased active PTH(1-84) fraction as a predictor of poor mortality in male hemodialysis patients. Osteoporos Int. 2013;24:2863–2870.
   PubMed Web of Science ®Google Scholar
• Mizumura Y, Mukaiyama Y, Osada H, et al. The reversed ratio of 1-84 PTH (whole PTH)/intact PTH in a patient on hemodialysis associated with primary hyperparathyroidism. Clin Nephrol. 2008;69:310–312.
   PubMed Web of Science ®Google Scholar
• Brossard JH, Cloutier M, Roy L, et al. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values. J Clin Endocrinol Metab. 1996;81:3923–3929.
   PubMed Web of Science ®Google Scholar
• Slatopolsky E, Finch J, Clay P, et al. A novel mechanism for skeletal resistance in uremia. Kidney Int. 2000;58:753–761.
   PubMed Web of Science ®Google Scholar
• Sneddon WB, Syme CA, Bisello A, et al. Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50). J Biol Chem. 2003;278:43787–43796.
   PubMed Web of Science ®Google Scholar
• Kiuchi MG, Ho JK, Nolde JM, et al. Sympathetic activation in hypertensive chronic kidney disease – a stimulus for cardiac arrhythmias and sudden cardiac death? Front Physiol. 2019;10:1546.
   PubMed Web of Science ®Google Scholar
• Hayano J, Takahashi H, Toriyama T, et al. Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with end-stage renal disease. Nephrol Dial Transplant. 1999;14(6):1480–1488.
   PubMed Web of Science ®Google Scholar
• Oikawa K, Ishihara R, Maeda T, et al. Prognostic value of heart rate variability in patients with renal failure on hemodialysis. Int J Cardiol. 2009;131(3):370–377.
   PubMed Web of Science ®Google Scholar
• Buonacera A, Boukhris M, Tomasello SD, et al. Impact of left ventricular remodeling and renal function on 24h-ECG recordings and cardiovascular outcome in elderly hypertensive patients. Eur J Intern Med. 2016;29:71–77.
   PubMed Web of Science ®Google Scholar
• Randon RB, Rohde LE, Comerlato L, et al. The role of secondary hyperparathyroidism in left ventricular hypertrophy of patients under chronic hemodialysis. Braz J Med Biol Res. 2005;38:1409–1416.
   PubMed Web of Science ®Google Scholar
• Duque EJ, Elias RM, Moyses RMA. Parathyroid hormone: a uremic toxin. Toxins. 2020;12(3):189.
   Web of Science ®Google Scholar
• Zhang L, Yang S, Chen J, et al. Associations of parathyroid hormone levels and mineral parameters with heart rate variability in patients with end-stage renal disease. Int Urol Nephrol. 2017;49:1079–1085.
   PubMed Web of Science ®Google Scholar
• Chen H, Cui Y, Xing C, et al. Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease. Int Urol Nephrol. 2018;50:2279–2288.
   PubMed Web of Science ®Google Scholar
• Kim YH, Jung KI, Song CH. Effects of serum calcium and magnesium on heart rate variability in adult women. Biol Trace Elem Res. 2012;150(1–3):116–122.
   PubMed Web of Science ®Google Scholar
• Yokoyama A, Kikuchi K, Kawamura Y. [Heart rate variability, arrhythmia and magnesium in hemodialysis patients]. Clin Calcium. 2005;15:226–232.
   PubMedGoogle Scholar
• Lee SA, Lee MJ, Ryu GW, et al. Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients. Osteoporos Int. 2016;27(9):2717–2726.
   PubMed Web of Science ®Google Scholar
• Tentori F, Wang M, Bieber BA, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. CJASN. 2015;10(1):98–109.
   PubMed Web of Science ®Google Scholar
• Ulusoy S, Ozkan G, Guvercin B, et al. The relation between variability of intact parathyroid hormone, calcium, and cardiac mortality in hemodialysis patients. Artif Organs. 2016;40:1078–1085.
   PubMed Web of Science ®Google Scholar
• Allawi AAD. Malnutrition, inflamation and atherosclerosis (MIA syndrome) in patients with end stage renal disease on maintenance hemodialysis (a single centre experience). Diabetes Metab Syndr. 2018;12:91–97.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Ortiz ME, Pendon-Ruiz de Mier MV, Rodriguez M. Parathyroidectomy in dialysis patients: indications, methods, and consequences. Semin Dial. 2019;32:444–451.
   PubMed Web of Science ®Google Scholar
• Schipper LG, Fleuren HW, van den Bergh JP, et al. Treatment of osteoporosis in renal insufficiency. Clin Rheumatol. 2015;34(8):1341–1345.
   PubMed Web of Science ®Google Scholar
• Chou FF, Chen JB, Huang SC, et al. Changes in serum FGF23 and Klotho levels and calcification scores of the abdominal aorta after parathyroidectomy for secondary hyperparathyroidism. Am J Surg. 2019;218:609–612.
   PubMed Web of Science ®Google Scholar